For ChIP assay retroviruses, selected, and induced to differentiate in conventional differentiation medium (DMEM supplemented with 2% horse serum, 30 mg/ml penicillin, and 100 mg/ml streptomycin). The differentiation medium was changed every 24 h until day 5, when the photos were taken. Scale bar 500 µm.
(B) Samples of C2C12 cells undergoing differentiation were taken daily until day 5 post-induction, and whole cell lysates were prepared. The lysates were subjected to western blot with antibodies against Med23, myosin heavy chain (MHC), myogenin, and TBP. TBP and a non-specific band are shown as loading controls.
SUPPLEMENTAL EXPERIMENTAL PROCEDURES
Cell Culture And Adipocyte Differentiation Med23 -/-MEFs were isolated from 9.5-day embryos and self-immortalized using standard procedures. Immortalized MEFs were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% FBS (Hyclone) in 5% CO2. 293T and 3T3-L1 cells were grown in DMEM containing 10% newborn calf serum (NCS) in 5% CO2.
To induce MEFs to differentiate into adipocytes, cells were plated at a density of 5×10 4 per 3.5 cm dish in cell culture medium with or without BMP4 (10 µg/L). Two days after the cells reached confluence, the cells were treated with culture medium containing differentiation cocktail (5 mg/L insulin (Sigma), 0.5 mM IBMX (3-isobutyl-1-methylxanthine) (Sigma), 1 µM dexamethasone (Sigma)), with or without 0.5 mg/L troglitazone (Sigma). After 48 hr, the cells were switched to medium containing 5 mg/L insulin, and the medium was replenished every 2 days. 3T3-L1 cells were induced to differentiate by adding 1 mg/L insulin, 0.5 mM IBMX, and 1 µM dexamethasone for 48 hr and then switched to medium with 1 mg/L insulin. RNA was collected for real-time PCR analysis at the indicated time points. Lipid droplets were stained with Oil Red O (Sigma).
Insulin Stimulation And Signaling Inhibition
Insulin was directly added to the cell culture medium to a final concentration of 5 mg/L. The cells were harvested for total RNA extraction at the indicated time points. For signaling inhibition, the cells were pretreated with various signaling inhibitors 30 min before the addition of insulin. RNA was isolated 30 min after the addition of insulin. The chemical inhibitors used and their final concentrations in the medium are 10 µM U0126 (LC Laboratories; specific to MEK1/2), 30 µM H89 (LC Laboratories; specific to PKA), 30 µM SB203580 (LC Laboratories; specific to p38), 20 µM LY294002 (Calbiochem; specific to PI3K), and 1 µM wortmannin (Calbiochem; specific to PI3K). The effect of wortmannin on Krox20 expression is equivalent to that of LY294002 (data not shown).
Retrovirus Plasmids And Infection
The human Med23 cDNA was amplified by PCR from an expression vector (pCS2-Med23) and cloned into the pMSCV/Puro and pMSCV/Hygro vectors (Clontech). The mouse Egr1 and Elk1 cDNAs were cloned into the pMSCV/Hygro vector (Clontech). The KOD Hot Start DNA Polymerase kit (TOYOBO) was used to mutate Ser-383 and -389 of pMSCV-Elk1 to alanine. The pMSCV-Krox20, pMSCV-PPARγ2, and pMSCV-C/EBPβ plasmids have been described previously (Chen et al., 2005) .
For knockdown of Med23 and Elk1 in 3T3-L1 cells, retrovirus-mediated siRNA expression was used. The targeted sequence was determined using the Whitehead Institute siRNA designing tool and verified by BLAST searches to ensure specificity. As recommended by Clontech for the RNAi-Ready pSIREN-RetroQ system, two complementary oligos for each targeted sequence were designed, annealed, and ligated into the BamHI/EcoRI-linearized pSIREN-RetroQ vector. The resulting construct, upon packaging into retroviruses, allows for the stable expression of the siRNA hairpin specific for the target gene. The sequences of the oligonucleotides cloned into pSIREN-RetroQ were si-Med23, gagataagtaagttacatg; si-Elk1, agttggtggatgcagagga; and si-Ctrl, gtgcgctgctggtgccaac. Retroviruses were generated following the cotransfection of recombinant pMSCV or pSiren-RetroQ plasmids with pCL10A1 helper plasmid into 293T cells using Lipofectamine 2000 (Invitrogen). Tissue culture supernatants containing retroviruses were harvested 48 hr later and passed though a 0.45 µm filter. Cells were plated into 6-well plates before retroviral infection. Virus-containing supernatants were supplemented with 20 µg/ml polybrene and added to the cells for a spin infection procedure, which was performed in the 6-well plates by centrifugation at 2500 rpm at 30°C for 1.5 h. MEFs were selected with 50 µg/ml puromycin and 3T3-L1 cells were selected with 300 µg/ml hygromycin or 5 µg/ml puromycin. One representative result from at least two siRNA experiments is shown.
Real-Time PCR and Western Blot Analysis
Total RNA was isolated from cells using TRIZOL (Invitrogen). The first-strand cDNA was generated using MMLV transcriptase (Promega), and real-time PCR was performed in triplicate using a SYBR Green PCR master mix in an Eppendorf Mastercycler. All values were normalized to the level of EF2 mRNA, which is constitutively expressed and not changed during the time course of the experiments. Primer sequences used in the experiments are included in the supplemental Table 2 . The western blot was performed using an ECL kit (Pierce) based on the manufacturer's recommendations. HRP-conjugated secondary antibodies were purchased from the Jackson Laboratory.
Microarray Analysis
Affymetrix Mouse Genome 430 2.0 expression arrays were probed with cDNA synthesized from total RNA isolated from 3T3-L1 cells treated for 30 min with 5 µg/ml insulin as described above. The data were analyzed using GCOS1.4 software. Med23-RNAi and insulin-induction were considered two factors in the two-way ANOVA analysis. Med23-RNAi down-regulated genes were selected by RNAi comparison at p-values <0.01 and >1.5 fold down-regulation, whereas insulin-responsive genes were selected by insulin-induction at p-values <0.01 and >1.5 fold induction. The overlapping set of selected genes is listed in supplemental Table 1 .
Soluble Recombinant MED23 Protein Production And Purification
The His-Flag-Med23-expressing baculovirus was generated using the Bac-to-Bac Baculovirus Expression system (Invitrogen), as specified by the manufacturer. Briefly, the PCR-generated hMed23 cDNA from pCS2+hMed23 was subcloned into the pFASTBac-HTc plasmid, and the Flag sequence was added to the N terminus to generate the N-terminal 6xHis-Flag-tagged fusion. This plasmid was introduced into DH10-Bac cells to produce the His-Flag-Med23 baculovirus plasmid (His-Flag-Med23-Bac). His-Flag-Med23-Bac plasmid was then transfected into Tn5 cells to recover recombinant baculovirus Med23-BAC. Tn5 cells (three 10 cm plates) were then infected with Med23-BAC, harvested 72 h post-infection at 2500 rpm, and lysed in 3 ml cytoplasm lysis buffer (20 mM HEPES, pH 7.9, 0.1% Triton X-100, 5 mM β-mercaptoethanol) with 30 µl PMSF (0.1 M) for 30 min at 4 ºC. After centrifugation at 15,000 g for 20 min, the supernatant was bound to 200 µl of Ni 2+ resin (Qiagen) in low flow speed three times at 4 ºC. The resin was washed three times in 1 ml of 20 mM imidazole washing buffer (50 mM NaH 2 PO 4 , 300 mM NaCl, pH 8.0) and then twice with 1 ml of 40 mM imidazole washing buffer. The purified Med23 was then eluted from the resin with 3 ml of 0.25 M imidazole elution buffer (50 mM NaH 2 PO 4 , 300 mM NaCl, pH 8.0, 10% glycerol). For Ni 2+ pull down experiment, the Ni-Med23 beads were prepared without elution and stored in PBS at 4 ºC.
Preparation of Recombinant GST-Elk1c and Ni-NTA Pull Down
The pGEX-Elk1c plasmid encodes the C-terminal amino acids 307-428 of human Elk1 fused to glutathione S-transferase. Elk1 307-428 was PCR amplified from HeLa cDNA and ligated into pGEX-4t-2 using the BamH1 and NotI sites. The GST-Elk1 fusion protein was purified as described (Guan and Dixon, 1991) . Recombinant ERK2 and ATP were purchased from NEB. The purified GST-Elk1 (100 µg) was treated with activated ERK2 and ATP at 30 ºC and then incubated at 65 ºC to inactivate Erk2. The GST-Elk1 (1 ml diluted in D300) was incubated with Ni-Med23 beads (40 µl of 50% PBS slurry) overnight at 4℃, washed twice with 1 ml of D300 (no EDTA, with 0.1% NP40), and finally washed twice with 1 ml of D500 (no EDTA, with 0.1% NP40). SDS loading buffer (50 µl) was added to the beads, and the samples were boiled at 100 ºC for 5 min.
Elk1 Mutagenesis And Luciferase Assay
Multiple serine residues within the Elk1 activation domain of Gal4-Elk1 (307-428) were mutated by site-directed mutagenesis to alanine residues using the KOD Hot Start DNA Polymerase kit (TOYOBO). 293T cells at 90% confluency (in 12-well plates) were transfected with a 5×Gal-E1B-TATA-luciferase reporter construct (250 µg per well) and the Gal4-Elk1 activation domain or Gal4-ELk1 mutants (50 µg per well), in the absence or presence of a plasmid expressing active MEKK (Stratagene, 25 µg per well). Additionally, a plasmid expressing Renilla luciferase was cotransfected (50 µg per well). Transfection was performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's recommendations. At 48 hours post-transfection, the cells were lysed, and the luciferase expression was
